FDA Inspection 1007284 — Piedmont Athens Regional Medical Ctr

Piedmont Athens Regional Medical Ctr — FEI 1073250

The FDA completed an inspection of Piedmont Athens Regional Medical Ctr on April 6, 2017 in Athens, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Athens, GA (United States)